Keyphrases
Adjusted Odds Ratio
6%
African Women
7%
AIDS Indicator Survey
5%
AIDS/HIV
8%
Antiretroviral Therapy
38%
Breastfeeding Women
7%
Confidence Interval
18%
COVID-19
5%
Dapivirine
8%
Dapivirine Vaginal Ring
20%
Gestational Age
5%
Herpes Simplex Virus 2 (HSV-2)
5%
HIV Infection
8%
HIV Patients
18%
HIV Prevention
11%
HIV Research Network
6%
HIV-1 Prevention
10%
Human Immunodeficiency Virus Type 1 (HIV-1)
8%
Intimate Partner Violence
6%
Kenya
10%
Low Birth Weight
5%
Malawi
23%
Men Who Have Sex with Men
7%
Menses
5%
National Population-based Survey
6%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
5%
Open-label Extension
6%
People Living with HIV (PLHIV)
24%
PEPFAR
6%
Phase II Trial
6%
Pre-exposure Prophylaxis (PrEP)
5%
Pregnant Women
7%
Preterm Birth
9%
Randomized Trial
8%
Sexual Behavior
8%
South Africa
11%
Southern Africa
7%
Sub-Saharan Africa
25%
Systemic Inflammation
6%
Tenofovir
7%
Trial Network
7%
Tuberculosis Incidence
6%
Uganda
5%
Women of Reproductive Age
6%
Zimbabwe
5%
Medicine and Dentistry
Antiretroviral Therapy
18%
Cohort Effect
5%
COVID-19
5%
Cross Sectional Study
5%
Dapivirine
16%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
15%
Low and Middle Income Countries
5%
Men Who Have Sex with Men
13%
Menstruation
5%
Odds Ratio
5%
Placebo
5%
Pre-Exposure Prophylaxis
8%
Premature Labor
7%
Prevalence
20%
Prospective Cohort Study
7%
Randomized Clinical Trial
7%
Tenofovir
8%
Vagina Ring
16%
